Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells

Reproductive Biology and Endocrinology

Volumn 8, Issue , 2010, Pages

  Friel, Anne M ^a,b   Zhang, Ling ^a   Curley, Michael D ^a,b   Therrien, Vanessa A ^a   Sergent, Petra A ^a   Belden, Sarah E ^c   Borger, Darrell R ^c   Mohapatra, Gayatry ^a,b   Zukerberg, Lawrence R ^a,b   Foster, Rosemary ^a,b   Rueda, Bo R ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CD133 ANTIGEN; AZACITIDINE; DRUG DERIVATIVE; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL; CARCINOGENICITY; CONTROLLED STUDY; ENDOMETRIUM CANCER; EPIGENETICS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METHYLATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; TUMOR XENOGRAFT; ANIMAL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL TRANSFORMATION; ENDOMETRIUM TUMOR; FEMALE; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY;

MUS;

ANIMALS; ANTIGENS, CD; AZACITIDINE; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIAL NEOPLASMS; EPIGENOMICS; FEMALE; GLYCOPROTEINS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES;

EID: 78649508055     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-8-147     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009, 59(4):225-249. 10.3322/caac.20006, 19474385.
2. Lax SF. Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch 2004, 444(3):213-223. 10.1007/s00428-003-0947-3, 14747944.
3. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000, 13(3):295-308. 10.1038/modpathol.3880051, 10757340.
4. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006, 24(29):4783-4791. 10.1200/JCO.2006.06.7173, 17028294.
5. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer 2000, 7(4):227-242. 10.1677/erc.0.0070227, 11174845.
6. Gargett CE, Schwab KE, Zillwood RM, Nguyen HP, Wu D. Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 2009, 80(6):1136-1145. 10.1095/biolreprod.108.075226, 2849811, 19228591.
7. Hubbard SA, Friel AM, Kumar B, Zhang L, Rueda BR, Gargett CE. Evidence for cancer stem cells in human endometrial carcinoma. Cancer Res 2009, 69(21):8241-8248. 10.1158/0008-5472.CAN-08-4808, 19843861.
8. Padykula HA, Coles LG, Okulicz WC, Rapaport SI, McCracken JA, King NW, Longcope C, Kaiserman-Abramof IR. The basalis of the primate endometrium: a bifunctional germinal compartment. Biol Reprod 1989, 40(3):681-690. 10.1095/biolreprod40.3.681, 2758097.
9. Chan RW, Schwab KE, Gargett CE. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 2004, 70(6):1738-1750. 10.1095/biolreprod.103.024109, 14766732.
10. Kato K, Yoshimoto M, Kato K, Adachi S, Yamayoshi A, Arima T, Asanoma K, Kyo S, Nakahata T, Wake N. Characterization of side-population cells in human normal endometrium. Hum Reprod 2007, 22(5):1214-1223. 10.1093/humrep/del514, 17283036.
11. Chan RW, Gargett CE. Identification of label-retaining cells in mouse endometrium. Stem Cells 2006, 24(6):1529-1538. 10.1634/stemcells.2005-0411, 16456137.
12. Cervello I, Martinez-Conejero JA, Horcajadas JA, Pellicer A, Simon C. Identification, characterization and co-localization of label-retaining cell population in mouse endometrium with typical undifferentiated markers. Hum Reprod 2007, 22(1):45-51. 10.1093/humrep/del332, 16923745.
13. Friel AM, Sergent PA, Patnaude C, Szotek PP, Oliva E, Scadden DT, Seiden MV, Foster R, Rueda BR. Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells. Cell Cycle 2008, 7(2):242-249. 10.4161/cc.7.2.5207, 18256549.
14. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004, 101(39):14228-14233. 10.1073/pnas.0400067101, 521140, 15381773.
15. Alvi AJ, Clayton H, Joshi C, Enver T, Ashworth A, Vivanco MM, Dale TC, Smalley MJ. Functional and molecular characterisation of mammary side population cells. Breast Cancer Res 2003, 5(1):R1-8. 10.1186/bcr563, 154129, 12559051.
16. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci USA 2006, 103(30):11154-11159. 10.1073/pnas.0603672103, 1544057, 16849428.
17. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3(7):730-737. 10.1038/nm0797-730, 9212098.
18. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432(7015):396-401. 10.1038/nature03128, 15549107.
19. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65(23):10946-10951. 10.1158/0008-5472.CAN-05-2018, 16322242.
20. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445(7123):111-115. 10.1038/nature05384, 17122771.
21. Ferrandina G, Martinelli E, Petrillo M, Prisco MG, Zannoni G, Sioletic S, Scambia G. CD133 antigen expression in ovarian cancer. BMC Cancer 2009, 9:221. 10.1186/1471-2407-9-221, 19583859.
22. Ferrandina G, Bonanno G, Pierelli L, Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella S, Paglia A, et al. Expression of CD133-1 and CD133-2 in ovarian cancer. Int J Gynecol Cancer 2008, 18(3):506-514. 10.1111/j.1525-1438.2007.01056.x, 17868344.
23. Rutella S, Bonanno G, Procoli A, Mariotti A, Corallo M, Prisco MG, Eramo A, Napoletano C, Gallo D, Perillo A, et al. Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors. Clin Cancer Res 2009, 15(13):4299-4311. 10.1158/1078-0432.CCR-08-1883, 19509143.
24. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, Olweus J, Kearney J, Buck DW. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90(12):5002-5012.
25. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997, 90(12):5013-5021.
26. Baba T, Convery PA, Matsumura N, Whitaker RS, Kondoh E, Perry T, Huang Z, Bentley RC, Mori S, Fujii S, et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells. Oncogene 2009, 28(2):209-218. 10.1038/onc.2008.374, 18836486.
27. Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT, et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett 2009, 279(1):13-21. 10.1016/j.canlet.2009.01.016, 19232461.
28. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008, 86(9):1025-1032. 10.1007/s00109-008-0357-8, 2585385, 18535813.
29. Yi JM, Tsai HC, Glockner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G, Eberhart CG, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Res 2008, 68(19):8094-8103. 10.1158/0008-5472.CAN-07-6208, 2744404, 18829568.
30. Hibi K, Sakata M, Kitamura YH, Sakuraba K, Shirahata A, Goto T, Mizukami H, Saito M, Ishibashi K, Kigawa G, et al. Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer. Anticancer Res 2009, 29(6):2235-2237.
31. Zhou F, Cui C, Ge Y, Chen H, Li Q, Yang Z, Wu G, Sun S, Chen K, Gu J, et al. {alpha}2,3-Sialylation Regulates the Stability of Stem Cell Marker CD133. J Biochem
32. Tabu K, Sasai K, Kimura T, Wang L, Aoyanagi E, Kohsaka S, Tanino M, Nishihara H, Tanaka S. Promoter hypomethylation regulates CD133 expression in human gliomas. Cell Res 2008, 18(10):1037-1046. 10.1038/cr.2008.270, 18679414.
33. Curley MD, Therrien VA, Cummings CL, Sergent PA, Koulouris CR, Friel AM, Roberts DJ, Seiden MV, Scadden DT, Rueda BR, et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells 2009, 27(12):2875-2883.
34. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008, 68(11):4311-4320. 10.1158/0008-5472.CAN-08-0364, 2553722, 18519691.
35. Nakamura M, Kyo S, Zhang B, Zhang X, Mizumoto Y, Takakura M, Maida Y, Mori N, Hashimoto M, Ohno S, et al. Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol 2010, 41(11):1516-1529. 10.1016/j.humpath.2010.05.006, 20800872.
36. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100(7):3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
37. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Treatment modalities in endometrial cancer. Curr Opin Oncol 2007, 19(5):479-485. 10.1097/CCO.0b013e32827853c0, 17762575.
38. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445(7123):106-110.
39. Alvero AB, Fu HH, Holmberg J, Visintin I, Mor L, Marquina CC, Oidtman J, Silasi DA, Mor G. Stem-like ovarian cancer cells can serve as tumor vascular progenitors. Stem Cells 2009, 27(10):2405-2413. 10.1002/stem.191, 2783765, 19658191.
40. Alvero AB, Chen R, Fu HH, Montagna M, Schwartz PE, Rutherford T, Silasi DA, Steffensen KD, Waldstrom M, Visintin I, et al. Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 2009, 8(1):158-166.
41. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, Costa C, Zhang F, Guo X, Rafii S. Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133. Blood 2004, 103(6):2055-2061. 10.1182/blood-2003-06-1881, 14630820.